Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for protection against one-lung ventilation-associated lung injury during lobectomy
ChiCTR-IPR-17010332Phase 4Not yet recruiting
- Sponsor
- Shanghai Pulmonary Hospital
- Start
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of dexmedetomidine in not applicable; "lung injury" is not a specific disease (2 arms), sponsored by Shanghai Pulmonary Hospital. Primary endpoint: oxygenation index. Planned start Oct 2016; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
not applicable; "lung injury" is not a specific disease
Beyond the preview
Go deeper on ChiCTR-IPR-17010332.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17010332.